The disclosed embodiments relate to an in-situ foam core stress mitigation component and method of manufacturing of same.
Vehicle manufacturers attempt to reduce the weight of the vehicles in order to enhance the fuel economy of the vehicle. Often the reduction in weight compromises the strength of component parts. Recently, regulations, such as ECE17 and Federal Motor Vehicle Safety Standards (FMVSS), such as FMVSS202A, have mandated a stiffer component structure for vehicle seats.
Recent components, meeting ECE17 regulation, such as seat frames comprising a plastic blend of polycarbonate and acrylonitrile butadiene styrene (PC/ABS), have increased the cost of seat frames as well as increased the weight of the seat frames relative to the blowmolded polyethylene seat frames that they replaced.
Manufacturers need to connect seat frame components, including the PC/ABS seat frames, to fixed platforms in the vehicles. Current methods, such as bolting directly through a plastic component, result in areas of very high stress concentration. Very high stress concentration may result in premature fatigue failure of the plastic component or other structural damage to the plastic component during high acceleration and deceleration events of the vehicle.
What is needed is a lightweight component that mitigates the stress concentration while remaining economically competitive.
Except where expressly indicated, all numerical quantities in the description and claims, indicated amounts of material or conditions of reaction and/or use are to be understood as modified by the word “about” in describing the broadest scope of the present invention. Practice within the numerical limits stated should be desired and independently embodied. Ranges of numerical limits may be independently selected from data provided in the tables and description. The description of the group or class of materials as suitable for the purpose in connection with the present invention implies that the mixtures of any two or more of the members of the group or classes are suitable. The description of constituents in chemical terms refers to the constituents at the time of addition to any combination specified in the description and does not necessarily preclude chemical interaction among constituents of the mixture once mixed. The first definition of an acronym or other abbreviation applies to all subsequent uses herein of the same abbreviation and applies mutatis mutandis to normal grammatical variations of the initially defined abbreviation. Unless expressly stated to the contrary, measurement of a property is determined by the same techniques previously or later referenced for the same property. Also, unless expressly stated to the contrary, percentage, “parts of,” and ratio values are by weight, and the term “polymer” includes “oligomer,” “co-polymer,” “terpolymer,” “pre-polymer,” and the like.
It is also to be understood that the invention is not limited to specific embodiments and methods described below, as specific composite components and/or conditions to make, of course, vary. Furthermore, the terminology used herein is used only for the purpose of describing particular embodiments of the present invention and is not intended to be limiting in any way.
It must also be noted that, as used in the specification and the pending claims, the singular form “a,” “an,” and “the” comprise plural reference unless the context clearly indicates otherwise. For example, the reference to a component in the singular is intended to comprise a plurality of components.
Seat frame foot 30 having skin 12 and 14 comprising a polypropylene composition having a thickness ranging between 0.025 inches and 0.25 inches with in-situ foam core 22 density ranging from 1 lb/ft3 to 5 lbs/ft3 formed of expanded polypropylene (EPP) that is expanded using steam, passes ECE 17. The seat frame foot 30 is a portion of a seat frame that surprisingly reduces the weight by 5 to 15 pounds of a seat frame relative to a PC/ABS 60/40 composition equivalent.
The seat component can alternatively be a seat back with a through hole embossment formed at the hinge or seat back latch attachment point to receive mounting fasteners.
In at least one embodiment, skin 12 or 14 thickness may range from 0.02 inches to 0.5 inches. In another embodiment, skin 12 or 14 thickness may range from 0.125 inches to 0.25 inches.
In at least one embodiment, in-situ core 22 thickness may range from 0.15 inches to 6 inches. In another embodiment, in-situ foam core 22 thickness may range from 0.2 inches to 4 inches. In another embodiment, in-situ foam core 22 thickness may range from 0.5 inches to 1 inch.
Skins 12 and/or 14, in at least one embodiment, are formed of a composition of any moldable composition. Non-limiting examples of the composition include, but are not limited to, a liquid silicone rubber, a synthetic rubber, a natural rubber, a liquid crystal polymer, a synthetic polymer resin, and a natural polymer resin. In another embodiment, skins 12 and/or 14 are formed of a composition of a thermoplastic polymer, a thermoset polymer, or blends thereof having a viscosity ranging from 0.1 grams/10 min. to 40 grams/10 min. The viscosity is measured according to ASTM D-1238 at 190° C. with a 2.16 kg weight. In yet another embodiment, skins 12 and/or 14 are formed of a composition of a polyolefin including a polypropylene and polyethylene having a viscosity ranging from 1 grams/10 min. to 30 grams/10 min. In yet another embodiment, skins 12 and/or 14 are formed of a composition of a vinyl-containing composition, including polystyrene and acrylonitrile-butadiene-styrene (ABS).
In-situ foam core 22, in at least one embodiment, is formed of a composition of any fluid-expandable material. Examples of fluid-expandable material include, but are not limited to, a polyolefin polymer composition, a biopolymer expandable bead, an alkenyl aromatic polymer or copolymer, a vinyl aromatic polymer resin composition, and a polystyrene polymer composition. In at least one embodiment, the polyolefin polymer composition includes polyolefin homopolymers, such as low-density, medium-density, and high-density polyethylenes, isotactic polypropylene, and polybutylene, and copolymers of ethylene or polypropylene with other polymerized bull monomers such as ethylene-propylene copolymer, and ethylene-vinyl acetate copolymer, and ethylene-acrylic acid copolymer, and ethylene-ethyl acrylate copolymer, polystyrene, and ethylene-vinyl chloride copolymer. These polyolefin resins may be used alone or in combination. Preferably, expanded polypropylene (EPP) particles, cross-linked expanded polyethylene (xEPE) particles, polyphenyloxide (PPO) particles, biomaterial particles, such as polyactic acid (PLA), and polystyrene particles are used. In at least one embodiment, the polyolefin polymer is a homopolymer providing increased strength relative to a copolymer. It is also understood that some of the particles may be unexpanded, also known as pre-puff, partially and/or wholly pre-expanded without exceeding the scope or spirit of the contemplated embodiments.
Pre-expanded beads, in at least one embodiment, are the resultant bead after raw bead has undergone a first expansion step of a two-step expansion process for beads. During the first expansion step, raw bead is expanded to 2% to 95% of the fully expanded bead size. The fully expanded bead is the bead that forms in-situ foam core 22. In another embodiment, pre-expanded bead is the result of the first expansion step where raw bead is expanded from 25% to 90% of the fully-expanded bead size.
A fluid for the second expansion step of the two-step expansion process for beads causes the pre-expanded beads to expand completely to form the fully expanded beads. Examples of the fluid include, but are not limited to, steam and superheated steam. In certain embodiments, after expansion with the heated fluid, the beads in contact with the skins 12 and 14 are bonded to the skin forming a thermal bond with in-situ foam core 22 therebetween.
Polyolefin beads and methods of manufacture of pre-expanded polyolefin beads suitable for making the illustrated embodiments are described in Japanese Patent Nos. JP60090744, JP59210954, JP59155443, JP58213028, and U.S. Pat. No. 4,840,973. Non-limiting examples of expanded polyolefins are ARPLANK®, and ARPRO®, available from JSP, Inc. (Madison Heights, Mich.). The expanded polypropylene, such as JSP ARPRO™ EPP, has no external wall.
In at least one embodiment, in-situ foam core 22 density, after expansion by steam, ranges from 1 lb/ft3 to 25 lbs/ft3. In at least one embodiment, in-situ foam core 22 density ranges from 1.5 lbs/ft3 to 15 lbs/ft3. In at least one embodiment, in-situ foam core 22 density ranges from 2 lbs/ft3 to 9 lbs/ft3. In at least one embodiment, in-situ foam core 22 density ranges from 3 lbs/ft3 to 6 lbs/ft3.
In at least one embodiment, skins 12 and/or 14, with a range of 0.025 inch thickness to 0.1 inch thickness, are comprised of metallocene polypropylene. Such a combination is found to improve adhesion between skins 12 and/or 14 and in-situ foam core from 22 formed of EPP.
Turning now to
In at least one embodiment of the method of forming the seat frame foot 30 is blow molding. Mold portions define a blow mold cavity into which a molten polypropylene parison is extruded from an extruder. The parison defines an internal parison cavity.
The blow mold portions close upon the parison. Gas is injected into the parison cavity inflating the hot parison while still soft and deformable to conform to the walls of the blow mold cavity defining the skins 12 and 14 having a cavity which may be larger than the original parison cavity. Sliding mold portions push on the parison to form the embossments 16 and 18 and junction 20.
Feed apertures are cut through skins 12 and 14. Staged filling begins as partially pre-expanded EPP beads are introduced to the cavity through an EPP introduction device fitted to the blow mold portions. At a first stage, EPP beads are introduced through the feed aperture. Filling at the next stages continues until the cavity is filled.
The EPP introduction device is withdrawn from the apertures. The apertures are plugged. Steam injection needles are inserted through blow mold portion and skins 12 and 14 into the filled cavity. A fluid for the second expansion step of the two-step expansion process for beads causes the pre-expanded beads to expand completely to form the fully expanded beads. Examples of the fluid include, but are not limited to, steam and superheated steam.
Steam is injected through steam injection needles into partially pre-expanded beads causing the beads to expand forming the in-situ foam core 22 in the area that was previously the cavity. The contacting layer of beads bond to skins 12 and 14 forming a thermal bond.
In at least one embodiment, in-situ foamed core 22 is formed by expanding a pre-expanded bead inside a blow molded shell. In at least one embodiment, pre-expanded bead is re-compressed by 10 vol. % to 70 vol. % when being dispersed. Upon being dispersed, pre-expand bead re-expands within the cavity.
While exemplary embodiments are described above, it is not intended that these embodiments describe all possible forms of the invention. Rather, the words used in the specification are words of description rather than limitation, and it is understood that various changes may be made without departing from the spirit and scope of the invention. Additionally, the features of various implementing embodiments may be combined to form further embodiments of the invention.
This application claims the benefit of U.S. provisional application Ser. No. 61/721,070 filed Nov. 1, 2012, the disclosure of which is hereby incorporated in its entirety by reference.
Number | Name | Date | Kind |
---|---|---|---|
776342 | McCormick | Nov 1904 | A |
1588778 | Sorensen | Jun 1926 | A |
2784417 | Strand | Mar 1957 | A |
2983963 | Jodell et al. | May 1961 | A |
3062337 | Zittle | Nov 1962 | A |
3111787 | Chamberlain | Nov 1963 | A |
3132417 | Irwin | May 1964 | A |
3277220 | Plymale et al. | Oct 1966 | A |
3389195 | Gianakos et al. | Jun 1968 | A |
3400429 | Ludwig | Sep 1968 | A |
3466700 | Harrison | Sep 1969 | A |
3468097 | Mack | Sep 1969 | A |
3563845 | Stevens | Feb 1971 | A |
3598312 | Hamilton | Aug 1971 | A |
3745998 | Rose | Jul 1973 | A |
3774968 | Fenton | Nov 1973 | A |
3813040 | Heinemeyer | May 1974 | A |
3935044 | Daly | Jan 1976 | A |
4361656 | Mostafa | Nov 1982 | A |
4492663 | Reinfeld et al. | Jan 1985 | A |
4546899 | Williams | Oct 1985 | A |
4573741 | Kirchner-Carl | Mar 1986 | A |
4621002 | Kuhlmann et al. | Nov 1986 | A |
4651494 | Van Wagoner | Mar 1987 | A |
4680909 | Stewart | Jul 1987 | A |
4762438 | Dewing | Aug 1988 | A |
4825089 | Lindsay | Apr 1989 | A |
4840973 | Kuwabara et al. | Jun 1989 | A |
5018329 | Hasan et al. | May 1991 | A |
5023042 | Efferding | Jun 1991 | A |
5028377 | Hendry | Jul 1991 | A |
5055350 | Neefe | Oct 1991 | A |
5093053 | Eckardt et al. | Mar 1992 | A |
5252270 | Haardt et al. | Oct 1993 | A |
5275860 | D'Luzansky et al. | Jan 1994 | A |
5306266 | Freeland | Apr 1994 | A |
5345814 | Cur et al. | Sep 1994 | A |
5366674 | Hattori et al. | Nov 1994 | A |
5437750 | Rinse | Aug 1995 | A |
5505810 | Kirby et al. | Apr 1996 | A |
5532034 | Kirby et al. | Jul 1996 | A |
5665285 | Hattori et al. | Sep 1997 | A |
5711073 | Tippmann et al. | Jan 1998 | A |
5713518 | Fox et al. | Feb 1998 | A |
5759459 | Eckardt et al. | Jun 1998 | A |
5786394 | Slaven | Jul 1998 | A |
5824261 | Berdan | Oct 1998 | A |
5858159 | Holbrook et al. | Jan 1999 | A |
5866224 | Ang et al. | Feb 1999 | A |
5956905 | Weidrich | Sep 1999 | A |
6179215 | Shea | Jan 2001 | B1 |
6196760 | Sinclair | Mar 2001 | B1 |
6230981 | Hill et al. | May 2001 | B1 |
6241926 | Cutler | Jun 2001 | B1 |
6375892 | Thomas | Apr 2002 | B2 |
6605343 | Motoi et al. | Aug 2003 | B1 |
6685333 | Bieberdorf | Feb 2004 | B1 |
6692183 | Godfrey | Feb 2004 | B2 |
6931809 | Brown et al. | Aug 2005 | B1 |
6938968 | Tanimoto et al. | Sep 2005 | B2 |
6955576 | Yeh | Oct 2005 | B2 |
6972144 | Roth et al. | Dec 2005 | B2 |
7201112 | Jolley | Apr 2007 | B2 |
7201625 | Yeh | Apr 2007 | B2 |
7219479 | Durning et al. | May 2007 | B2 |
7358280 | Berghmans et al. | Apr 2008 | B2 |
7377828 | Cheung | May 2008 | B2 |
7401998 | Wilson et al. | Jul 2008 | B2 |
7485352 | Yuasa et al. | Feb 2009 | B2 |
7537413 | Brugos | May 2009 | B1 |
7931210 | Pike et al. | Apr 2011 | B1 |
7950592 | Yuan | May 2011 | B2 |
7976749 | Volkel et al. | Jul 2011 | B2 |
20020124531 | Mossbeck et al. | Sep 2002 | A1 |
20030081999 | Godfrey | May 2003 | A1 |
20030181536 | Roth | Sep 2003 | A1 |
20030224675 | Yeh | Dec 2003 | A1 |
20040172964 | Brachert et al. | Sep 2004 | A1 |
20040176001 | Yeh | Sep 2004 | A1 |
20040232254 | Kowalski | Nov 2004 | A1 |
20050001048 | Skoblenick et al. | Jan 2005 | A1 |
20050101201 | Yeh | May 2005 | A1 |
20050188637 | Yeh | Sep 2005 | A1 |
20050215138 | Yeh | Sep 2005 | A1 |
20050272323 | Yeh | Dec 2005 | A1 |
20060003044 | Dinello et al. | Jan 2006 | A1 |
20060030467 | Mellott | Feb 2006 | A1 |
20060078382 | Wilson et al. | Apr 2006 | A1 |
20060105650 | Yeh | May 2006 | A1 |
20060110993 | Yeh | May 2006 | A1 |
20060131437 | Thiagarajan et al. | Jun 2006 | A1 |
20060134401 | Yeh | Jun 2006 | A1 |
20060223897 | Sasaki | Oct 2006 | A1 |
20070015421 | Yeh | Jan 2007 | A1 |
20070040293 | Lane et al. | Feb 2007 | A1 |
20070160798 | Yeh | Jul 2007 | A1 |
20080081153 | Yeh | Apr 2008 | A1 |
20080083835 | Girardi et al. | Apr 2008 | A1 |
20080125502 | Reichman et al. | May 2008 | A1 |
20080142611 | Scobie | Jun 2008 | A1 |
20080166539 | Yeh | Jul 2008 | A1 |
20080242169 | Yeh | Oct 2008 | A1 |
20080305304 | Yeh | Dec 2008 | A1 |
20090011667 | Hayward et al. | Jan 2009 | A1 |
20090100780 | Mathis et al. | Apr 2009 | A1 |
20090133354 | Spear | May 2009 | A1 |
20100028654 | Takase et al. | Feb 2010 | A1 |
20100116180 | Roth et al. | May 2010 | A1 |
20110115120 | Hattori et al. | May 2011 | A1 |
20110180959 | Donnelly | Jul 2011 | A1 |
20120031912 | Wang | Feb 2012 | A1 |
20120102884 | Roberts, Jr. | May 2012 | A1 |
20120104110 | Roberts, Jr. | May 2012 | A1 |
20120240451 | Ricks | Sep 2012 | A1 |
20120328889 | Hayashi et al. | Dec 2012 | A1 |
20130140860 | Naughton et al. | Jun 2013 | A1 |
Number | Date | Country |
---|---|---|
0542302 | May 1993 | EP |
0535147 | Sep 1996 | EP |
58213028 | Dec 1983 | JP |
S59145125 | Aug 1984 | JP |
59155443 | Sep 1984 | JP |
59210954 | Nov 1984 | JP |
60090744 | May 1985 | JP |
06166112 | Jun 1994 | JP |
07195536 | Aug 1995 | JP |
9119867 | Dec 1991 | WO |
2011103284 | Aug 2011 | WO |
Entry |
---|
Website, Specter, www.mmh.com Sep. 2009, “Modern Materials Handling, The Rise of the Plastic Pallet.” 4 Pages. |
Website www.jsp.com, 2006, “Arplank, Expanded bead foam packaging materials, Material Properties, Auto/Mil Specs.” 21 Pages. |
Website, Manning, www.mmh.com Oct. 2008, Retrived on Jan. 4, 2011, “Modern Materials Handling, Choosing Plastic.” 2 Pages. |
Vehicle Certification Agency Oct. 25, 2007, pp. 1-6, Test Report No. ESH178571, “Test Report: Seat Strength.” |
ECE Agreement Jul. 31, 2002, Regulation No. 17, “Concerning the adoption of uniform technical prescriptions for wheeled vehicles, equipment and parts which can be fitted and / or used on wheeled vehicles and the conditions for reciprocal recognition of approvals granted on the basis of these prescriptions.” |
GB Examination Report for GB 1308511.3, Completed by the GB Patent Office, dated Aug. 10, 2016, 5 Pages. |
Number | Date | Country | |
---|---|---|---|
20140120307 A1 | May 2014 | US |
Number | Date | Country | |
---|---|---|---|
61721070 | Nov 2012 | US |